Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bolen

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Occupational and Environmental Medicine|December 22, 2006
The validation of work-related self-reported asthma exacerbationAimee R Bolen, Paul K Henneberger, Xiaoming Liang, et al.
Journal of Hematology & Oncology|June 8, 2020
A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYALaurie H Sehn, Maurizio Martelli, Marek Trněný, et al.
The Canadian Nurse|November 1, 1993
Needlestick injuries: the shock and realityA Moorhouse, R Bolen, J Evans, et al.
Blood Advances|February 17, 2019
PD-L1 and tumor-associated macrophages in de novo DLBCLRonald McCord, Christopher R Bolen, Hartmut Koeppen, et al.
Southern Medical Journal|February 1, 1993
Prevention of preterm birth: early detection and aggressive treatment with terbutalineR T Adkins, J E Van Hooydonk, P L Bressman, et al.
BMC Cancer|March 3, 2022
Prognostic mutational subtyping in de novo diffuse large B-cell lymphomaEugene Kim, Yanwen Jiang, Tao Xu, et al.
Clinical and Vaccine Immunology : CVI|December 11, 2012
Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virusFeng Qian, Christopher R Bolen, Chunxia Jing, et al.
Nucleic Acids Research|May 27, 2009
Meningococcus genome informatics platform: a system for analyzing multilocus sequence typing dataLee S Katz, Chris R Bolen, Brian H Harcourt, et al.
American Journal of Hematology|August 21, 2020
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapyFarheen Mir, Federico Mattiello, Andrew Grigg, et al.
Frontiers in Immunology|June 25, 2019
Quantitative Comparison of Conventional and t-SNE-guided Gating AnalysesShadi Toghi Eshghi, Amelia Au-Yeung, Chikara Takahashi, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Occupational and Environmental Medicine|December 22, 2006
The validation of work-related self-reported asthma exacerbationAimee R Bolen, Paul K Henneberger, Xiaoming Liang, et al.
Journal of Hematology & Oncology|June 8, 2020
A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYALaurie H Sehn, Maurizio Martelli, Marek Trněný, et al.
The Canadian Nurse|November 1, 1993
Needlestick injuries: the shock and realityA Moorhouse, R Bolen, J Evans, et al.
Blood Advances|February 17, 2019
PD-L1 and tumor-associated macrophages in de novo DLBCLRonald McCord, Christopher R Bolen, Hartmut Koeppen, et al.
Southern Medical Journal|February 1, 1993
Prevention of preterm birth: early detection and aggressive treatment with terbutalineR T Adkins, J E Van Hooydonk, P L Bressman, et al.
BMC Cancer|March 3, 2022
Prognostic mutational subtyping in de novo diffuse large B-cell lymphomaEugene Kim, Yanwen Jiang, Tao Xu, et al.
Clinical and Vaccine Immunology : CVI|December 11, 2012
Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virusFeng Qian, Christopher R Bolen, Chunxia Jing, et al.
Nucleic Acids Research|May 27, 2009
Meningococcus genome informatics platform: a system for analyzing multilocus sequence typing dataLee S Katz, Chris R Bolen, Brian H Harcourt, et al.
American Journal of Hematology|August 21, 2020
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapyFarheen Mir, Federico Mattiello, Andrew Grigg, et al.
Frontiers in Immunology|June 25, 2019
Quantitative Comparison of Conventional and t-SNE-guided Gating AnalysesShadi Toghi Eshghi, Amelia Au-Yeung, Chikara Takahashi, et al.
Pageof 5